| Company | Date | Position | Consensus β | Price Target β | 2-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
RMD
Resmed
|
Oct 30, 2026 | HOLD |
Buy
+4.7% avg upside
27 analysts
|
$250.00
8.74% Upside
|
+4.2% | Β· |
|
IRTC
Irhythm Technologies
|
Oct 06, 2026 | BUY |
Strong Buy
+32.2% avg upside
21 analysts
|
$150.00
21.57% Upside
|
-16.4% | Β· |
|
SOLV
Solventum Corporation
|
Aug 06, 2026 | HOLD |
Buy
+12.8% avg upside
16 analysts
|
$89.00
9.44% Upside
|
+3.7% | Β· |
|
PRCT
PROCEPT BioRobotics
|
Aug 05, 2026 | HOLD |
Buy
+59.9% avg upside
18 analysts
|
$19.00
1.00% Downside
|
+23.0% | Β· |
|
LMAT
Lemaitre Vascular
|
May 06, 2026 | HOLD |
Strong Buy
+21.2% avg upside
16 analysts
|
$104.00
28.58% Upside
|
-30.6% | Β· |
|
ITGR
Integer Holdings
|
Oct 23, 2025 | HOLD |
Buy
-18.9% avg upside
16 analysts
|
$80.00
36.74% Downside
|
+71.8% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.